Generic competition · all medicines · read 12 November 2026
Is there a generic of Verapamil Hydrochloride, and who makes it?
Verapamil Hydrochloride appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 19 generic makers listed as marketed across them. Where both are dated, the first generic approval came between 1.6 and 8.9 years after the first brand approval. This is the Orange Book's listing, not a forecast.
Method designed and maintained by Vincent Wesley Couey (ORCID 0009-0005-6869-308X). Data compiled automatically from the Orange Book data files, downloaded 12 November 2026. How these pages are made
- Verapamil Hydrochloride appears in 5 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 19 generic makers listed as marketed across them.
- Where both are dated, the first generic approval came between 1.6 and 8.9 years after the first brand approval.
- Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.
Tablet, Oral
One to three generic makers listed
Every brand product here is listed as discontinued. 2 generic makers with 6 generic products listed as marketed; the first generic approval is dated 24 September 1986.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Watson Laboratories Inc | 1 October 1986 | 3 |
| Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc | 5 April 1988 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Tablet, Extended Release, Oral
Four or more generic makers listed
Every brand product here is listed as discontinued. 4 generic makers with 11 generic products listed as marketed; the first generic approval is dated 31 July 1992.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Strides Pharma International Ag | 25 May 1999 | 2 |
| Glenmark Pharmaceuticals Ltd | 17 September 2009 | 3 |
| Cadila Pharmaceuticals Ltd | 5 May 2017 | 3 |
| Zydus Lifesciences Global Fze | 24 November 2025 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Injectable, Injection
Four or more generic makers listed
Every brand product here is listed as discontinued. 8 generic makers with 8 generic products listed as marketed; the first generic approval is dated 12 November 1985.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Eugia Pharma Specialities Ltd | 6 July 2020 | 1 |
| Gland Pharma Ltd | 15 October 2020 | 1 |
| Zydus Pharmaceuticals Usa Inc | 15 October 2020 | 1 |
| Heritage Pharmaceuticals Inc Dba Avet Pharmaceuticals Inc | 17 March 2022 | 1 |
| Mankind Pharma Ltd | 15 June 2022 | 1 |
| Fresenius Kabi Usa Llc | 23 April 2024 | 1 |
| Aspiro Pharma Ltd | 13 November 2025 | 1 |
| Knack Pharmaceuticals Inc | 22 July 2026 | 1 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Solution, Intravenous
Four or more generic makers listed
Brand listed as marketed: Verapamil Hydrochloride. 5 generic makers with 13 generic products listed as marketed; the first generic approval is dated 6 May 1987.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Hospira Inc | 6 May 1987 | 3 |
| Somerset Therapeutics Llc | 18 June 2018 | 4 |
| Micro Labs Ltd | 28 December 2018 | 2 |
| Nephron Pharmaceuticals Corporation | 17 March 2020 | 2 |
| Caplin Steriles Ltd | 25 March 2020 | 2 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
Capsule, Extended Release, Oral
One to three generic makers listed
Brand listed as marketed: Verelan and Verelan Pm. 1 generic maker with 3 generic products listed as marketed; the first generic approval is dated 20 April 1999.
| Generic maker (applicant) | First approval | Products |
|---|---|---|
| Mylan Pharmaceuticals Inc | 20 April 1999 | 3 |
Patents and exclusivities still listed
No unexpired patent or exclusivity is listed against the marketed brand products in this group.
US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.
What do pharmacies pay for Verapamil Hydrochloride?
The CMS NADAC survey tracks what pharmacies pay to acquire Verapamil Hydrochloride: 14 products with year-end prices from 2013 to 2026. See the acquisition cost history on RxGrab. It is a pharmacy cost, not a retail price, and this page does not say how it relates to the number of makers listed above.
Where can you go from this result?
Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.